✦ LIBER ✦

The efficacy and safety of 28-day treatment with ziprasidone in schizophrenia/schizoaffective disorder

✍ Scribed by E. Harrigan

Book ID: 119175718
Publisher: Elsevier Science
Year: 1996
Tongue: French
Weight: 132 KB
Volume: 11
Category: Article
ISSN: 0924-9338
DOI: 10.1016/0924-9338(96)89348-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-22-8 - The efficacy and safety of 28-d

P-22-8 - The efficacy and safety of 28-day treatment with ziprasidone in schizophrenia/schizoaffective disorder

✍ E. Harrigan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 281 KB

14-115 - The efficacy of ziprasidone in

14-115 - The efficacy of ziprasidone in schizophrenia and schizoaffective disorder: An update

✍ E. Keck Jr.; Edmund P. Harrigan; Karen R. Reeves 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 280 KB

Double-blind comparison of the safety an

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

✍ Steven G. Potkin; Masaaki Ogasa; Josephine Cucchiaro; Antony Loebel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 444 KB

576 - The efficacy and safety of ziprasi

576 - The efficacy and safety of ziprasidone 80 mg/day and 160mg/day in schizophrenia and schizoaffecfive disorder

✍ David Daniel; Karen Reeves; Edmund P Harrigan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Efficacy and safety of long-acting rispe

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi

Effectiveness, tolerability, and safety

Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: Results of a multi-centre observational trial

✍ Duerten Kudla; Martin Lambert; Sabine Domin; Siegfried Kasper; Dieter Naber 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 201 KB